2005N-0038 - Adverse Event Reporting to Investigational Review Boards Public Hearing
FDA Comment Number : EC5
Submitter : Dr. Robert F. Reder Date & Time: 03/04/2005 08:03:11
Organization : Purdue Pharma L.P.
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
See attachment.